Castle’s DecisionDx-Melanoma Test Outperforms Staging and CP-GEP in Identifying Patients at Low Risk of SLN Positivity

May 1, 2025

Skin Cancer Month News: The Skin Cancer Foundation Photobiology Committee Updates Criteria for Its Seal of Recommendation

May 1, 2025

DecisionDx-Melanoma Identifies Early Distant Metastases

April 30, 2025

AACR Skin Cancer News: Pretrained Machine Learning Models May Aid NMSC Diagnosis in Resource-limited Settings

April 30, 2025

Clinical Trial Update: More Patients Added to Medicus Pharma’s Phase 2 Study of D-MNA for BCC

April 21, 2025

Pinworm Medication Shows Promise in Treating Merkel Cell Carcinoma

April 18, 2025

NHS News: Melanoma Patients Receive Fast-tracked Access to Cancer Vaccine Trial

April 16, 2025

Now On Tour: Sun Bum’s Trust The Bum Tour to Hit 10 Cities

April 14, 2025

Non-invasive Skin Cancer Diagnostic Technology Update: SciBase Rolls Out the Next Generation of Nevisense

April 11, 2025

Protein Implicated in Parkinson’s Disease May Also Drive Melanoma

April 10, 2025

PCPC, Health Advocates Launch #WearSunscreen Campaign

April 7, 2025

New Research Confirms Castle Biosciences’ DecisionDx-Melanoma Test’s Ability to ID Patients Who Can Safely Forgo SLNB

April 3, 2025